NasdaqGS - Delayed Quote USD
Replimune Group, Inc. (REPL)
9.78
-0.10
(-1.06%)
At close: June 13 at 4:00:00 PM EDT
10.09
+0.31
+(3.14%)
After hours: June 13 at 7:38:24 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ASTLEY-SPARKE PHILIP Director | Sale | May 20, 2025 | 1,405,070 |
| COFFIN ROBERT Director | Sale | May 16, 2024 | 1,821,870 |
| ESPOSITO PAMELA Officer | Sale | Sep 12, 2023 | 263,436 |
| HILL EMILY LUISA Chief Financial Officer | Sale | May 20, 2025 | 143,522 |
| LOVE COLIN Chief Operating Officer | Sale | May 16, 2024 | 777,345 |
| PATEL SUSHIL Chief Executive Officer | Sale | May 20, 2025 | 343,576 |
| SARCHI CHRISTOPHER Officer | Sale | May 20, 2025 | 128,296 |
| SCHWENDENMAN ANDREW Officer | Sale | May 20, 2025 | 68,284 |
| XYNOS KONSTANTINOS Officer | Sale | May 20, 2025 | 146,933 |
Related Tickers
KALV KalVista Pharmaceuticals, Inc.
12.96
-0.99%
YMAB Y-mAbs Therapeutics, Inc.
4.7100
+1.73%
STOK Stoke Therapeutics, Inc.
11.53
-2.45%
ANAB AnaptysBio, Inc.
23.32
-0.38%
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
CRNX Crinetics Pharmaceuticals, Inc.
31.77
-1.24%
KURA Kura Oncology, Inc.
6.44
-3.30%
NUVB Nuvation Bio Inc.
1.7300
-4.42%
ORIC ORIC Pharmaceuticals, Inc.
9.63
-0.41%
EWTX Edgewise Therapeutics, Inc.
15.29
-0.84%